about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Roche vaults to the front of the NL­RP3 clin­i­cal race, pay­ing $448M up­front to bag In­fla­zome

5 years ago
Deals

Roche looks to ge­net­ic mod­i­fiers for new drug tar­gets, team­ing up with Dutch biotech in $375M deal

5 years ago
Deals

#ES­MO20: As­traZeneca aims to spur PRO­found shift in prostate can­cer treat­ment with Lyn­parza OS da­ta

5 years ago
R&D
Pharma

#ES­MO20: Out to beat Tagris­so, J&J touts 100% ORR for EGFR bis­pe­cif­ic/TKI com­bo — fu­el­ing a quick leap to PhI­II

5 years ago
R&D

#ES­MO20: As­traZeneca bur­nish­es Tagris­so's ad­ju­vant NSCLC pro­file with 'un­prece­dent­ed' re­duc­tion in brain mets. Can ...

5 years ago
R&D
Pharma

Seat­tle Ge­net­ic­s' Astel­las-part­nered ADC nails con­fir­ma­to­ry PhI­II in urothe­lial can­cer

5 years ago
R&D
Pharma

Roche says a sec­ond tri­al of Actem­ra re­vives hopes for IL-6. What now?

5 years ago
Coronavirus

Past a turn­ing point, Finch scores $90M to com­plete the fi­nal stretch for oral mi­cro­bio­me ther­a­py

5 years ago
Financing

Sarep­ta faces an­oth­er gene ther­a­py hic­cup as Re­genxbio sues over Jim Wilson's patent

5 years ago
Cell/Gene Tx

Ex-Al­ler­gan CMO takes the helm at Lewis Cant­ley's metas­ta­sis-fo­cused biotech start­up

5 years ago
People

Ver­sant teams up with Stan­ford gene edit­ing ex­perts on a $45M next-gen play — mar­ry­ing CRISPR and AAV to fix sick­le ...

5 years ago
Financing
Startups

Cyg­nal's Pearl Huang re­cruits for­mer Mer­ck col­league John Wag­n­er to re­al­ize broad ex­oneur­al vi­sion in the clin­ic

5 years ago
People

Take­da opens cell ther­a­py man­u­fac­tur­ing fa­cil­i­ty — tucked right in its Boston R&D hub

5 years ago
Cell/Gene Tx

Fol­low­ing job cuts and R&D re­struc­tur­ing, mi­cro­cap mi­croR­NA play­er mi­Ra­gen brings in new CEO to right the ship

5 years ago
People

FDA shoots down Mallinck­rodt's re­demp­tion at­tempt, spurns rare kid­ney dis­ease drug for a sec­ond time

5 years ago
FDA+

Trump ups the stakes with 'grand­dad­dy of them al­l' drug pric­ing ex­ec­u­tive or­der. But he could be run­ning out of time

5 years ago
Pharma

News brief­ing: Roche shows off more MS, NMOSD da­ta; Gala­pa­gos and Gilead clear PhI­Ia pri­ma­ry end­points but re­port ...

5 years ago
News Briefing

Savara's long-reign­ing duo both re­sign in the wake of CF bust

5 years ago
People

Covid-19 roundup: NIH spot­lights blood thin­ners in its next big tri­al; All it took was a pan­dem­ic to get JPM out of ...

5 years ago
Coronavirus

A 'break­through' PD-1? From Chi­na? FDA says why not for rare can­cer

5 years ago
China
FDA+

As Chi­na's tech gi­ants catch on­to biotech, Baidu plots $2B start­up fo­cused on di­ag­no­sis, AI drug dis­cov­ery

5 years ago
Financing
China

An­i­mal da­ta in hand, Nes­san Berming­ham banks $91.5M for At­las-backed RNA edit­ing play

5 years ago
Financing

FL56+FL57= in­fi­nite pos­si­bil­i­ties? Flag­ship's hy­brid start­up takes ma­chine learn­ing in drug dis­cov­ery to the next ...

5 years ago
Startups
AI

Covid-19 roundup: Fau­ci re­it­er­ates Oc­to­ber vac­cine OK 'un­like­ly'; Pfiz­er and BioN­Tech re­serve 200M dos­es for EU

5 years ago
Coronavirus
First page Previous page 66676869707172 Next page Last page
A service from the Financial Times